 | • レポートコード：MRC2-11QY10828 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は筋萎縮性側索硬化症（ALS）治療薬のグローバル市場について調査・分析したレポートです。種類別（リルゾール、エダラボン（ラジカバ）、CoQ10、ブチルフタリド、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別筋萎縮性側索硬化症（ALS）治療薬の競争状況、市場シェア ・世界の筋萎縮性側索硬化症（ALS）治療薬市場：種類別市場規模 2015年-2020年（リルゾール、エダラボン（ラジカバ）、CoQ10、ブチルフタリド、その他） ・世界の筋萎縮性側索硬化症（ALS）治療薬市場：種類別市場規模予測 2021年-2026年（リルゾール、エダラボン（ラジカバ）、CoQ10、ブチルフタリド、その他） ・世界の筋萎縮性側索硬化症（ALS）治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の筋萎縮性側索硬化症（ALS）治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の筋萎縮性側索硬化症（ALS）治療薬市場分析：米国、カナダ ・ヨーロッパの筋萎縮性側索硬化症（ALS）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの筋萎縮性側索硬化症（ALS）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の筋萎縮性側索硬化症（ALS）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの筋萎縮性側索硬化症（ALS）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Mitsubishi Tanabe Pharma、Mylan、Apotex、Glemark Generics、Sun Pharma、Covis Pharma、Lunan Pharma、CSPC Pharmaceutical、Ascend Laboratories、EISAI ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmental factors such as exposure to toxic or infectious agents, viruses, physical trauma, diet, and behavioral and occupational factors.
Amyotrophic Lateral Sclerosis Drugs includes Riluzole, Edaravone (Radicava), CoQ10, Baclofen, Butylphthalide and Others. These drugs prolong amyotrophic lateral sclerosis (ALS) survival and slow the disease’s progression in some people. Currently, only riluzole and edaravone have been approved for the treatment of ALS.
Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis Drugs Market
The global Amyotrophic Lateral Sclerosis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Amyotrophic Lateral Sclerosis Drugs Scope and Market Size
Amyotrophic Lateral Sclerosis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi
Mitsubishi Tanabe Pharma
Mylan
Apotex
Glemark Generics
Sun Pharma
Covis Pharma
Lunan Pharma
CSPC Pharmaceutical
Ascend Laboratories
EISAI
Market segment by Type, the product can be split into
Riluzole
Edaravone (Radicava)
CoQ10
Butylphthalide
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Drugs Revenue
1.4 Market by Type
1.4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Riluzole
1.4.3 Edaravone (Radicava)
1.4.4 CoQ10
1.4.5 Butylphthalide
1.4.6 Others
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Perspective (2015-2026)
2.2 Global Amyotrophic Lateral Sclerosis Drugs Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Amyotrophic Lateral Sclerosis Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Amyotrophic Lateral Sclerosis Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Amyotrophic Lateral Sclerosis Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Market Size
3.1.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue (2015-2020)
3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio
3.2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Drugs Revenue in 2019
3.3 Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Area Served
3.4 Key Players Amyotrophic Lateral Sclerosis Drugs Product Solution and Service
3.5 Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)
5.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
6.2 Amyotrophic Lateral Sclerosis Drugs Key Players in North America (2019-2020)
6.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
6.4 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
7.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Europe (2019-2020)
7.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
7.4 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)
8 China
8.1 China Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
8.2 Amyotrophic Lateral Sclerosis Drugs Key Players in China (2019-2020)
8.3 China Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
8.4 China Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
9.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Japan (2019-2020)
9.3 Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
9.4 Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
10.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)
11 India
11.1 India Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
11.2 Amyotrophic Lateral Sclerosis Drugs Key Players in India (2019-2020)
11.3 India Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
11.4 India Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
12.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
12.4 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Introduction
13.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Mitsubishi Tanabe Pharma
13.2.1 Mitsubishi Tanabe Pharma Company Details
13.2.2 Mitsubishi Tanabe Pharma Business Overview
13.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
13.2.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
13.2.5 Mitsubishi Tanabe Pharma Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview
13.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Introduction
13.3.4 Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 Apotex
13.4.1 Apotex Company Details
13.4.2 Apotex Business Overview
13.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Introduction
13.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
13.4.5 Apotex Recent Development
13.5 Glemark Generics
13.5.1 Glemark Generics Company Details
13.5.2 Glemark Generics Business Overview
13.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Introduction
13.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
13.5.5 Glemark Generics Recent Development
13.6 Sun Pharma
13.6.1 Sun Pharma Company Details
13.6.2 Sun Pharma Business Overview
13.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
13.6.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
13.6.5 Sun Pharma Recent Development
13.7 Covis Pharma
13.7.1 Covis Pharma Company Details
13.7.2 Covis Pharma Business Overview
13.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
13.7.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
13.7.5 Covis Pharma Recent Development
13.8 Lunan Pharma
13.8.1 Lunan Pharma Company Details
13.8.2 Lunan Pharma Business Overview
13.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
13.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
13.8.5 Lunan Pharma Recent Development
13.9 CSPC Pharmaceutical
13.9.1 CSPC Pharmaceutical Company Details
13.9.2 CSPC Pharmaceutical Business Overview
13.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Introduction
13.9.4 CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
13.9.5 CSPC Pharmaceutical Recent Development
13.10 Ascend Laboratories
13.10.1 Ascend Laboratories Company Details
13.10.2 Ascend Laboratories Business Overview
13.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Introduction
13.10.4 Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
13.10.5 Ascend Laboratories Recent Development
13.11 EISAI
10.11.1 EISAI Company Details
10.11.2 EISAI Business Overview
10.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Introduction
10.11.4 EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
10.11.5 EISAI Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Amyotrophic Lateral Sclerosis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Amyotrophic Lateral Sclerosis Drugs Revenue
Table 3. Ranking of Global Top Amyotrophic Lateral Sclerosis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Riluzole
Table 6. Key Players of Edaravone (Radicava)
Table 7. Key Players of CoQ10
Table 8. Key Players of Butylphthalide
Table 9. Key Players of Others
Table 10. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions (2015-2020)
Table 14. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Amyotrophic Lateral Sclerosis Drugs Market Growth Strategy
Table 20. Main Points Interviewed from Key Amyotrophic Lateral Sclerosis Drugs Players
Table 21. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2015-2020) (Million US$)
Table 22. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players (2015-2020)
Table 23. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2019)
Table 24. Global Amyotrophic Lateral Sclerosis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Amyotrophic Lateral Sclerosis Drugs Product Solution and Service
Table 27. Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 30. Global Amyotrophic Lateral Sclerosis Drugs Market Size Share by Type (2015-2020)
Table 31. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2021-2026)
Table 32. Global Amyotrophic Lateral Sclerosis Drugs Market Size Share by Application (2015-2020)
Table 33. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 34. Global Amyotrophic Lateral Sclerosis Drugs Market Size Share by Application (2021-2026)
Table 35. North America Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2019-2020)
Table 37. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2015-2020)
Table 39. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 40. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2015-2020)
Table 41. Europe Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2019-2020)
Table 43. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2015-2020)
Table 45. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2015-2020)
Table 47. China Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2019-2020) (Million US$)
Table 48. China Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2019-2020)
Table 49. China Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 50. China Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2015-2020)
Table 51. China Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 52. China Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2015-2020)
Table 53. Japan Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2019-2020)
Table 55. Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2015-2020)
Table 57. Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2019-2020)
Table 61. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2015-2020)
Table 63. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2015-2020)
Table 65. India Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2019-2020) (Million US$)
Table 66. India Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2019-2020)
Table 67. India Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 68. India Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2015-2020)
Table 69. India Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 70. India Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Amyotrophic Lateral Sclerosis Drugs Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Amyotrophic Lateral Sclerosis Drugs Market Share (2019-2020)
Table 73. Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2015-2020)
Table 75. Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2015-2020)
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Product
Table 80. Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 81. Sanofi Recent Development
Table 82. Mitsubishi Tanabe Pharma Company Details
Table 83. Mitsubishi Tanabe Pharma Business Overview
Table 84. Mitsubishi Tanabe Pharma Product
Table 85. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 86. Mitsubishi Tanabe Pharma Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Product
Table 90. Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 91. Mylan Recent Development
Table 92. Apotex Company Details
Table 93. Apotex Business Overview
Table 94. Apotex Product
Table 95. Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 96. Apotex Recent Development
Table 97. Glemark Generics Company Details
Table 98. Glemark Generics Business Overview
Table 99. Glemark Generics Product
Table 100. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 101. Glemark Generics Recent Development
Table 102. Sun Pharma Company Details
Table 103. Sun Pharma Business Overview
Table 104. Sun Pharma Product
Table 105. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 106. Sun Pharma Recent Development
Table 107. Covis Pharma Company Details
Table 108. Covis Pharma Business Overview
Table 109. Covis Pharma Product
Table 110. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 111. Covis Pharma Recent Development
Table 112. Lunan Pharma Business Overview
Table 113. Lunan Pharma Product
Table 114. Lunan Pharma Company Details
Table 115. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 116. Lunan Pharma Recent Development
Table 117. CSPC Pharmaceutical Company Details
Table 118. CSPC Pharmaceutical Business Overview
Table 119. CSPC Pharmaceutical Product
Table 120. CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 121. CSPC Pharmaceutical Recent Development
Table 122. Ascend Laboratories Company Details
Table 123. Ascend Laboratories Business Overview
Table 124. Ascend Laboratories Product
Table 125. Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 126. Ascend Laboratories Recent Development
Table 127. EISAI Company Details
Table 128. EISAI Business Overview
Table 129. EISAI Product
Table 130. EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020) (Million US$)
Table 131. EISAI Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Type: 2020 VS 2026
Figure 2. Riluzole Features
Figure 3. Edaravone (Radicava) Features
Figure 4. CoQ10 Features
Figure 5. Butylphthalide Features
Figure 6. Others Features
Figure 7. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Amyotrophic Lateral Sclerosis Drugs Report Years Considered
Figure 12. Global Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players in 2019
Figure 17. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue in 2019
Figure 19. North America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
筋萎縮性側索硬化症（ALS）の世界市場（～2026年） Amyotrophic lateral sclerosis (ALS) is a group of rare neurological diseases that mainly involve the nerve cells (neurons) responsible for controlling voluntary muscle movement. Developing medical infrastructure in the emerging economies is expected to drive the growth of Amyotrophic lateral scleros…- 筋萎縮性側索硬化症（ルーゲーリック病）治療の世界市場（～2026年） Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune resp…
- 筋萎縮性側索硬化症（ALS）治療の世界市場（～2026年） Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmenta…
- 多発性硬化症治療薬の世界市場（～2026年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…
- 外側上顆炎（テニス肘）の世界市場（～2026年） Lateral epicondylitis (tennis elbow) is a painful condition caused by the repetitive motion of arms and elbow. Market Analysis and Insights: Global Lateral Epicondylitis (Tennis Elbow) Market The global Lateral Epicondylitis (Tennis Elbow) market size is projected to reach US$ XX million by 2026, fr…